243 related articles for article (PubMed ID: 22789878)
21. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
[TBL] [Abstract][Full Text] [Related]
22. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.
Sinning JM; Losch J; Walenta K; Böhm M; Nickenig G; Werner N
Eur Heart J; 2011 Aug; 32(16):2034-41. PubMed ID: 21186238
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric analysis of cell membrane microparticles.
Gelderman MP; Simak J
Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
[TBL] [Abstract][Full Text] [Related]
24. Relationship between circulating microparticles and hypertension and other cardiac disease biomarkers in the elderly.
Usta Atmaca H; Akbas F; Aral H
BMC Cardiovasc Disord; 2019 Jul; 19(1):164. PubMed ID: 31288734
[TBL] [Abstract][Full Text] [Related]
25. Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging.
Stępień E; Kabłak-Ziembicka A; Czyż J; Przewłocki T; Małecki M
Expert Opin Ther Targets; 2012 Jul; 16(7):677-88. PubMed ID: 22616736
[TBL] [Abstract][Full Text] [Related]
26. Microparticles, vascular function, and atherothrombosis.
Rautou PE; Vion AC; Amabile N; Chironi G; Simon A; Tedgui A; Boulanger CM
Circ Res; 2011 Aug; 109(5):593-606. PubMed ID: 21852557
[TBL] [Abstract][Full Text] [Related]
27. Cellular mechanisms underlying the formation of circulating microparticles.
Morel O; Jesel L; Freyssinet JM; Toti F
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):15-26. PubMed ID: 21160064
[TBL] [Abstract][Full Text] [Related]
28. Altered profile of circulating microparticles in rheumatoid arthritis patients.
Rodríguez-Carrio J; Alperi-López M; López P; Alonso-Castro S; Carro-Esteban SR; Ballina-García FJ; Suárez A
Clin Sci (Lond); 2015 Apr; 128(7):437-48. PubMed ID: 25369551
[TBL] [Abstract][Full Text] [Related]
29. Microparticles and type 2 diabetes.
Leroyer AS; Tedgui A; Boulanger CM
Diabetes Metab; 2008 Feb; 34 Suppl 1():S27-32. PubMed ID: 18358424
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic role of endothelial microparticles in vasculitis.
Erdbruegger U; Grossheim M; Hertel B; Wyss K; Kirsch T; Woywodt A; Haller H; Haubitz M
Rheumatology (Oxford); 2008 Dec; 47(12):1820-5. PubMed ID: 18927191
[TBL] [Abstract][Full Text] [Related]
31. Pseudoexfoliative Glaucoma, Endothelial Dysfunction, and Arterial Stiffness: The Role of Circulating Apoptotic Endothelial Microparticles.
Bourouki E; Oikonomou E; Moschos M; Siasos G; Siasou G; Gouliopoulos N; Deftereos S; Miliou A; Zacharia E; Tousoulis D
J Glaucoma; 2019 Aug; 28(8):749-755. PubMed ID: 31188231
[TBL] [Abstract][Full Text] [Related]
32. Microparticles: biomarkers and beyond.
Burger D; Schock S; Thompson CS; Montezano AC; Hakim AM; Touyz RM
Clin Sci (Lond); 2013 Apr; 124(7):423-41. PubMed ID: 23249271
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis.
Sari I; Bozkaya G; Kirbiyik H; Alacacioglu A; Ates H; Sop G; Can G; Taylan A; Piskin O; Yildiz Y; Akkoc N
J Rheumatol; 2012 Mar; 39(3):594-9. PubMed ID: 22247348
[TBL] [Abstract][Full Text] [Related]
34. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.
Amabile N; Heiss C; Real WM; Minasi P; McGlothlin D; Rame EJ; Grossman W; De Marco T; Yeghiazarians Y
Am J Respir Crit Care Med; 2008 Jun; 177(11):1268-75. PubMed ID: 18310479
[TBL] [Abstract][Full Text] [Related]
35. The Role of Blood-Borne Microparticles in Inflammation and Hemostasis.
Suades R; Padró T; Badimon L
Semin Thromb Hemost; 2015 Sep; 41(6):590-606. PubMed ID: 26276937
[TBL] [Abstract][Full Text] [Related]
36. Microparticles in physiological and in pathological conditions.
Roos MA; Gennero L; Denysenko T; Reguzzi S; Cavallo G; Pescarmona GP; Ponzetto A
Cell Biochem Funct; 2010 Oct; 28(7):539-48. PubMed ID: 20941744
[TBL] [Abstract][Full Text] [Related]
37. Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women.
Rank A; Nieuwland R; Nikolajek K; Rösner S; Wallwiener LM; Hiller E; Toth B
Arch Gynecol Obstet; 2012 Apr; 285(4):1035-41. PubMed ID: 21986717
[TBL] [Abstract][Full Text] [Related]
38. Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study.
van Bussel BC; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Stehouwer CD
J Hypertens; 2012 Apr; 30(4):744-52. PubMed ID: 22343535
[TBL] [Abstract][Full Text] [Related]
39. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation.
Stępień E; Stankiewicz E; Zalewski J; Godlewski J; Zmudka K; Wybrańska I
Arch Med Res; 2012 Jan; 43(1):31-5. PubMed ID: 22306248
[TBL] [Abstract][Full Text] [Related]
40. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
